Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 4 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Recs

0
Player Avatar GMoneyCaps (70.19) Submitted: 12/13/2011 8:02:54 PM : Outperform Start Price: $32.79 BMY Score: -6.87

12/13

Report this Post Reply

Featured Broker Partners


Advertisement